Developing a Mobile Intervention to Reduce Suicidal Cognitions in Veterans
1 other identifier
interventional
10
1 country
1
Brief Summary
Suicide cognitions are conceptualized as enduring, chronic vulnerability factors that predispose individuals to suicidal crises. Therefore, modification of these beliefs may reduce suicidal thoughts and behaviors. The goal of this research is to develop, refine, and pilot-test a mobile intervention to reduce cognitions that contribute to elevated suicide risk and to assess the impact of reductions in suicide cognitions and anger cognitions on suicide risk and functioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 5, 2021
CompletedFirst Posted
Study publicly available on registry
May 11, 2021
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2024
CompletedResults Posted
Study results publicly available
February 20, 2025
CompletedFebruary 20, 2025
February 1, 2025
2.2 years
May 5, 2021
January 17, 2025
February 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Number of Participants Recruited
Participant feasibility expectation will be met if recruitment is 75% (i.e., N = 8) or greater of recruitment expectation (N = 10).
Through study completion (approximately 10 months)
Number of Enrolled Participants Who Complete the MIST Intervention
Treatment retention feasibility goal will be met if attrition from the MIST intervention is no more than 25% (i.e., not more than 3).
Post-MIST assessment visit (approximately one month after enrollment)
Number of Participants Reporting Satisfaction With MIST App: Client Satisfaction Questionnaire
Patient satisfaction will be assessed with item #7 from the Client Satisfaction Questionnaire. This item is scored on a scale of 1 to 4, with one indicating lower satisfaction and 4 indicating greater satisfaction. The patient satisfaction goal will be met if 80% or greater of participants indicate score a 3 or 4 on this item (i.e., at least 8 participants score a 3 or 4).
Post-MIST assessment visit (approximately one month after enrollment)
MIST App Utilization
MIST app utilization goal will be met if MIST app utilization rates are greater than 50% of expected use (i.e., mean # of sessions completed is greater than 10).
Post-MIST assessment visit (approximately one month after enrollment)
Study Arms (1)
MIST intervention followed by MIRA intervention
EXPERIMENTALThese are both mobile interventions that use interpretation bias modification (IBM) techniques to reduce cognitive biases. The MIST app targets suicidal cognitions and the MIRA app targets hostile interpretation bias (which contributes to anger). The MIRA application has already been developed, but the MIST application is newly developed based on the same procedures. All participants will complete the MIST intervention and provide feedback so that we can refine it. We will also be collecting EMA data on to examine how changes to suicide cognitions and hostile interpretation bias (by use of the two apps) affects suicidal ideation and functioning.
Interventions
This is an interpretation bias modification intervention that is designed to target cognitive factors that contribute to suicide risk. Participants will be instructed to complete at least 5 treatment sessions per week for a period of 4 weeks. Each session takes approximately 10 minutes.
This is an interpretation bias modification intervention that is designed to target hostile interpretation bias. Participants will be instructed to complete at least 5 treatment sessions per week for a period of 4 weeks. Each session takes approximately 10 minutes.
Eligibility Criteria
You may qualify if:
- Veterans 18 years or older
- Diagnosed with PTSD, established via the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
- Report a score of 12 on the 5-item Dimensions of Anger Reactions Scale
- Can read at least 6th grade level material
- Report a score of 1-3 (indicating ideation without intent) on the Columbia-Suicide Severity Rating Scale (C-SSRS)
- Have attended a mental health appointment within the past month, with another scheduled in the following month (i.e., be engaged in treatment with a mental health provider)
You may not qualify if:
- Diagnosed with bipolar or psychotic disorder.
- Current substance use disorder.
- Current imminent suicide risk or homicidal ideation requiring immediate intervention.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Durham VA Medical Center, Durham, NC
Durham, North Carolina, 27705-3875, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Angela Kirby
- Organization
- Durham VA Health Care System
Study Officials
- PRINCIPAL INVESTIGATOR
Kirsten H Dillon, PhD
Durham VA Medical Center, Durham, NC
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 5, 2021
First Posted
May 11, 2021
Study Start
December 1, 2021
Primary Completion
February 1, 2024
Study Completion
February 1, 2024
Last Updated
February 20, 2025
Results First Posted
February 20, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share